Pradeep Jaiswal
Papers
1
Total Citations
6
H-Index
1
About
Dr. Pradeep Jaiswal is a pioneering researcher at the forefront of nanomedicine and cancer theragnostics, whose work bridges the critical gap between nanotechnology and clinical oncology. His research focuses on the development of advanced nanoparticle systems and nanobots for targeted cancer therapy, addressing the persistent challenge of delivering therapeutics precisely to malignant cells while minimizing systemic toxicity. In his highly cited 2023 paper, "A Path of Novelty from Nanoparticles to Nanobots: Theragnostic Approach for Targeting Cancer Therapy," Dr. Jaiswal presents a comprehensive framework for integrating diagnostic and therapeutic functions into single nanoscale platforms, offering a transformative strategy to overcome the limitations of conventional cancer treatments. This work, which has already garnered significant attention with 6 citations in its first year, underscores his ability to synthesize complex interdisciplinary concepts into actionable pathways for drug delivery innovation. Dr. Jaiswal’s contributions are particularly notable for their translational potential, providing a roadmap for the next generation of smart nanocarriers that can simultaneously image tumors and deliver localized therapy. His research continues to inspire new directions in theragnostic nanomedicine, positioning him as a rising leader in the fight against cancer.
Research Focus
Key Achievements
Top Papers
- 1